GleamWall
中文EN

VSEE VSEE HEALTH, INC.

Services-Health Services · OTC · SEC CIK 1864531 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-5.4%
TTM net income YoY81.1%
TTM EPS YoY96.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin39.8%
Operating margin-99.7%
Net margin-113.8%
FCF margin-58.5%
EBITDA margin-76.1%

Returns

ROE-1,345.0%
ROA-71.5%
ROIC (approx.)-403.4%
Asset turnover0.63x

Leverage & solvency

Liabilities / assets54.6%
Debt / equity0.15x
Current ratio0.40x
Interest coverage-5.60x

Cash quality & payout

Operating cash flow / net income0.51x
Accruals ratio-35.4%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q2*2026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.50M$1.56M$3.16M$3.93M$2.32M$1.06M$3.32M$3.86M
Cost of revenue$1.19M$1.36M$1.96M$2.09M$1.19M$440,147$1.46M$1.43M
Gross profit$310,679$206,153$1.20M$1.83M$1.13M$615,044$1.86M$2.43M
SG&A expense$2.03M$2.25M$2.44M$2.92M$2.54M$1.73M$2.03M$3.72M
Operating income-$2.17M-$2.70M-$2.97M-$3.44M-$1.82M-$1.56M-$1.83M-$3.94M
Interest expense-$702$9,237$113,098$1.08M$745,965$222,363$9,237-$379,628
Pretax income-$2.85M-$3.10M-$2.58M-$7.80M-$42,456-$1.90M-$3.95M-$4.47M
Income tax$0-$17,899$23,738$50,437$0$1,728$13,505$1.15M
Net income-$2.85M-$1.74M-$2.60M-$7.85M-$289,745-$2.61M-$3.96M-$5.62M
EBITDA-$1.59M-$2.06M-$2.33M-$2.79M-$1.18M-$908,468-$1.18M-$3.27M
EPS (basic)——-0.05—-0.02-0.16-0.24—
EPS (diluted)——-0.05—-0.02-0.16-0.24—
Weighted avg. shares (diluted)734,93153.66M47.90M—206,86716.42M16.31M—
Balance sheet
Cash & equivalents$41,666$454,151$1.35M$5.05M$472,759$291,595$410,122$326,115
Receivables$2.17M$2.23M$2.67M$2.24M$2.58M$1.62M$1.85M$1.72M
Current assets$2.82M$3.27M$4.84M$8.37M$3.72M$2.56M$3.08M$3.02M
PP&E, net$91,170$113,178$265,245$294,987$418,860$506,070$597,578$680,242
Goodwill$4.92M$4.92M$4.92M$4.92M$4.92M$4.92M$4.92M$4.92M
Intangibles$7.13M$7.68M$8.23M$8.79M$9.34M$9.89M$10.44M$10.99M
Total assets$15.71M$16.73M$19.02M$22.41M$18.71M$18.21M$19.40M$19.99M
Current liabilities$9.59M$8.10M$11.79M$16.24M$23.42M$23.06M$21.98M$19.01M
Short-term debt$125,758$334,582$524,093$880,175$1.94M$1.46M$1.09M$433,983
Long-term debt$781,581$781,581$781,581$593,941$589,374$593,941$593,941$593,941
Total debt$907,339$1.12M$1.31M$1.47M$2.53M$2.05M$1.68M$1.03M
Total liabilities$10.69M$9.14M$12.70M$16.96M$24.28M$23.95M$22.89M$20.01M
Shareholders' equity$5.01M$7.59M$6.32M$5.45M-$5.58M-$5.74M-$3.50M-$18,488
Net debt$865,673$662,012-$40,458-$3.58M$2.06M$1.76M$1.27M$701,809
Shares outstanding806,07855.68M47.30M414,99517.02M16.42M16.42M16.30M
Cash flow statement
Operating cash flow-$437,838-$1.17M-$2.45M-$1.93M-$754,538-$324,601-$440,493-$2.97M
Capital expenditure-$97,712$73,248$26,752$7,152$0$3,593$11,873$4,760
Free cash flow-$340,126-$1.25M-$2.48M-$1.93M-$754,538-$328,194-$452,366-$2.98M
Investing cash flow-$56,823-$2,000-$126,752-$7,152-$7,310-$3,593-$11,873-$4,760
Financing cash flow$82,176$498,585-$1.34M$6.73M$943,012$209,667$536,373$977,832
Depreciation & amortization$576,795$640,185$646,619$653,792$644,017$647,599$647,037$671,706
Stock-based compensation$0$202,555$441,306$360,483$0$371,930$392,106$515,453
Share buybacks-$50,000$0$50,000$0$0$44$0$5,150

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.